01477.HK
Ocumension Therapeutics
HKSE · Healthcare · Biotechnology · CN
HKD 4.79
+3.90%Forward multiples
Based on analyst estimates
- P/E forward
- 100.13x
- P/E 2026E
- —
- P/E 2027E
- 49.90x
- P/E 2028E
- 12.88x
- P/S forward
- 5.11x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 0.92x
- Price / sales
- 3.57x
- Price / cash flow
- -260.25x
Enterprise value
- Enterprise value
- HKD 3.9B
- EV / sales
- 3.60x
- EV / EBITDA
- 123.14x
- EV / EBIT
- -27.09x
- Market cap
- HKD 3.9B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026